Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives
Karolin Roemhild(RWTH Aachen University), Twan Lammers(RWTH Aachen University), Yang Shi(Guiyang College of Traditional Chinese Medicine), Helena C. Besse(Utrecht University), Fabian Kießling(Universitätsklinikum Aachen), Chrit Moonen(Centre de Résonance Magnétique des Systèmes Biologiques), Daiki Omata(Teikyo University), Ruth Knüchel‐Clarke(RWTH Aachen University), Burcin Ozbakir(Utrecht University), Josbert M. Metselaar(Universitätsklinikum Aachen), Roel Deckers(Utrecht University), Clemens Bos(Utrecht University), Qingxue Sun(Universitätsklinikum Aachen), Wang Bi(Universitätsklinikum Aachen), Hans W. Scheeren(Universitätsklinikum Aachen), Quim Peña(DWI – Leibniz Institute for Interactive Materials), Gert Storm(Yong In University), Haijun Yu(Alibaba Group (China))
Cited by 18
Related Papers
Tumor targeting via EPR: Strategies to enhance patient responses
|Advanced Drug Delivery Reviews|2018|1.2k
Smart cancer nanomedicine
|Nature Nanotechnology|2019|1.2k
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
|Frontiers in Pharmacology|2018|937
Understanding ultrasound induced sonoporation: Definitions and underlying mechanisms
|Advanced Drug Delivery Reviews|2013|788
Sheddable Coatings for Long-Circulating Nanoparticles
|Pharmaceutical Research|2007|549